Droperidol (Compound)

Synonyms:droperidol, 548-73-2, Droleptan, Dehydrobenzperidol, Inapsine, Dridol, Properidol, Sintodril, Sintosian, Inapsin, Vetkalm, Halkan, Deidrobenzperidolo, Inopsin, Innovar, McN-JR-4749, Inappin, Innovan, Inoval, Dehidrobenzperidol, Droperidolum, Droperidolo, Leptofen, Thalamanol, Thalamonal, Innovar-vet, Dihidrobenzperidol, R-4749, McN-JR 4749, C22H22FN3O2, component of Innovar, R 4749, 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one, NSC 169874, 1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone, 1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone, NSC-169874, CHEMBL1108, 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, MLS000028671, CHEBI:4717, O9U0F09D5X, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one, 2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-, 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-, DTXSID6022973, Dehydrobenzoperidol, NSC169874, 1-{1-[4-(4-Fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one, 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one, NCGC00016504-01, CAS-548-73-2, Droperidolo [DCIT], SMR000058855, 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[d]imidazol-2-one, Droperidolum [INN-Latin], DTXCID302973, Neurolidol, Ina.psi.ne, Ina.psi.n, Ino.psi.n, 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, 2-Benzimidazolinone, 1-(1-(3-(p-fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-, 2-Benzimidazolinone, 1-[1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-, Droleptan (TN), 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one, 3-[1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-2,3,4,5-tetrahydropyridin-4-yl]-1~{H}-benzimidazol-2-one, CCRIS 9070, HSDB 3320, R4749, SR-05000001546, INAPSINE (TN), EINECS 208-957-8, BRN 0579168, UNII-O9U0F09D5X, Droperidol USP, 1-(1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-2h-benzimidazol-2-one, Prestwick_705, MFCD00083290, Innovar (Salt/Mix), Droperidol [USAN:USP:INN:BAN:JAN], HS-0065, Leptanal (Salt/Mix), Leptofen (Salt/Mix), Spectrum_001220, Thalamonal (Salt/Mix), DROPERIDOL [MI], DROPERIDOL [INN], DROPERIDOL [JAN], Innovar-vet (Salt/Mix), Opera_ID_1751, Prestwick0_000360, Prestwick1_000360, Prestwick2_000360, Prestwick3_000360, Spectrum2_001386, Spectrum3_001426, Spectrum4_000407, Spectrum5_001305, DROPERIDOL [HSDB], DROPERIDOL [USAN], DROPERIDOL [VANDF], DROPERIDOL [MART.], DROPERIDOL [USP-RS], DROPERIDOL [WHO-DD], SCHEMBL41426, BSPBio_000459, BSPBio_003132, KBioGR_000674, KBioSS_001700, 5-24-02-00388 (Beilstein Handbook Reference), MLS000758203, MLS001148120, MLS001424134, MLS002153445, DivK1c_000103, SPECTRUM1501002, SPBio_001372, SPBio_002380, BPBio1_000505, Droperidol (JP17/USP/INN), GTPL7172, DROPERIDOL [GREEN BOOK], DROPERIDOL [ORANGE BOOK], HMS500F05, KBio1_000103, KBio2_001700, KBio2_004268, KBio2_006836, KBio3_002352, DROPERIDOL [EP MONOGRAPH], NINDS_000103, DROPERIDOL [USP MONOGRAPH], HMS1569G21, HMS1921B03, HMS2051L06, HMS2092O16, HMS2096G21, HMS2232M09, HMS3374B05, HMS3393L06, HMS3652M12, HMS3713G21, HMS3885N03, Pharmakon1600-01501002, INNOVAR COMPONENT DROPERIDOL, HY-B1240, Tox21_110461, BDBM50017705, CCG-39004, NSC757819, s4096, STL453109, AKOS015960779, DROPERIDOL COMPONENT OF INNOVAR, Tox21_110461_1, AC-3537, CCG-101004, CS-4886, DB00450, NC00254, NSC-757819, 1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone, 3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one, IDI1_000103, NCGC00016504-02, NCGC00016504-03, NCGC00016504-04, NCGC00016504-05, NCGC00016504-06, NCGC00016504-09, NCGC00016504-17, NCGC00094884-01, NCGC00094884-02, SBI-0051628.P002, Droperidol 1.0 mg/ml in Dimethyl Sulfoxide, FT-0655846, SW220019-1, D00308, EN300-127036, F17346, AB00052191_04, AB00052191_05, WLN: T56 BMVNJ D3- DT6N CUTJ A3VR DF, A830387, L001006, Q174259, SR-05000001546-1, SR-05000001546-2, SR-05000001546-3, W-105600, BRD-K97158071-001-05-8, BRD-K97158071-001-08-2, Z1592690523, Droperidol, British Pharmacopoeia (BP) Reference Standard, Droperidol, European Pharmacopoeia (EP) Reference Standard, Droperidol, United States Pharmacopeia (USP) Reference Standard, 2H-Benzimidazol-2-one,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-, 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone, 1-1-[3-(p-Fluorobenzoyl)propyl]-1,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone, gamma-[4-(2-oxo-1-benzimidazolinyl)-1,2,3,6-tetrahydro-1-pyridyl]-p-fluorobutyrophenone, 1-(4-fluorophenyl)-4-[4-(2-hydroxy-1H-1,3-benzodiazol-1-yl)-1,2,3,6-tetrahydropyridin-1-yl]butan-1-one, 1-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-3H-benzoimidazol-2-one, 1-{1-[4-(4-Chloro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one(Droperidol), 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,5,6-tetrahydropyridin-4-yl] -1,3-dihydro-2H-benzimidazol}-2-one, 3-[1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one, USS

Pubchem:PUBCHEM:3168

Id:b1768b46-2fcb-58b8-8f35-3eceb828d19c

Description:nan